Anti-rabies monoclonal antibody - Serum Institute of India/MassBiologics

Alternative Names: RAB-1; Rabies human monoclonal antibody - Serum Institute of India; Rabishield; RMab; SII RMab

Latest Information Update: 04 Oct 2016

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Centers for Disease Control and Prevention; MassBiologics; University of Massachusetts Medical School
Developer Serum Institute of India
Class Antivirals; Monoclonal antibodies
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

04 Oct 2016 Launched for Rabies in India (IM) before October 2016(Serum Institute of India, October 2016)
06 Sep 2013 Isconova is now called Novavax AB
22 Aug 2013 Isconova has been acquired by Novavax

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com